|
|
|
|
|
|
| Abstract Search | Browse Program and Abstracts | Schedule-at-a-Glance | Conference Mission & Sponsors | Program Committee | Contact Us |
| # | Title |
|---|---|
| 228 | Inclusion of a Protein Booster in a DNA Priming and MVA Boosting Protocol for an AIDS Vaccine
S. L. Buge*1, M. Ma1, R. Amara2, L. Wyatt3, P. Earl3, B. Grimm4, F. Villinger4, J. Altman2, B. Moss3, S. I. Strapans2, N. L. Kozyr2, D. C. Montefiori5, Y. Xu2, S. O’Neil2, J. G. Herndon2, H. M. McClure2, H. Robinson2, and J. McNicholl1 1CDC, Atlanta, GA, USA; 2Regional Primate Ctr., Atlanta, GA, USA; 3NIH, Bethesda, MD, USA; 4Emory Univ. Sch. of Med., Atlanta, GA, USA; and 5Duke Univ. Med. Ctr., Durham, NC, USA |
| 229 | Enhancement of Cellular and Humoral Immune Responses to Human Immunodeficiency Virus Type 1 Gag and Pol by a GP-92 Fusion Protein Expressing Highly Immunogenic Gag p17/p24 and Pol p51 Antigens
D. Kmieciak1,2 and D. Kozbor*1 1Temple Univ., Philadelphia, PA, USA and 2Univ. Med. Sci., Poznan, Poland |
| 230 | Immunization Strategies to Augment Oral Vaccination with DNA and Viral Vectors Expressing HIV Envelope Glycoprotein
T. Naito*1, J. Gzyl1, E. Bolesta1, D. Kmieciak1, H. Pletcher2, and D. Kozbor1 1Temple Univ., Philadelphia, PA, USA and 2Univ. of Pennsylvania, Philadelphia, USA |
| 231 | Construction, GMP Production and Immunogenicity of a Subtype E/A HIV-1 Recombinant MVA (rMVA) for Clinical Evaluation in Southeast Asia
T. VanCott*1, P. Earl2, L. Steinmeyer1, L. Frampton1, J. Cox1, S. Ratto-Kim1, L. Jagodzinski1, C. Kakareka1, R. Olson3, J. L. Excler1, K. Eckels3, B. Moss2, and D. Birx1 1US Military HIV Program, Rockville, MD, USA; 2NIH, Bethesda, MD, USA; and 3Pilot Production Facility, WRAIR, Silver Spring, MD, USA |